[ad_1] Daiichi Sankyo-AstraZeneca gets BLA approved for lung cancer therapy in the U.S. [ad_2] Source link
Browsing: BLA
[ad_1] FDA accepts Adaptimmune BLA for afami-cel, decision expected by Aug. 4 [ad_2] Source link
[ad_1] Iovance up 15% on FDA acceptance of lifileucel application for melanoma [ad_2] Source link
[ad_1] Iovance up 13% on completing Biologics License Application submission for lifileucel [ad_2] Source link